Aug 12
OFIX · Orthofix Medical Inc. · Documents
$8.92
-0.80 (-8.23%)
At close · Nov 5
Return incl. dividend (before tax)
Play latest call
Q2 2026 earnings call transcript
Market Cap
$392.26M
Shares
40.73M
Volume · Nov 5
1.36M
Avg daily vol (3M)
404.83K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →
2026
Aug 5
Quarterly report
10-Q
FY2026 Q2, ended Jun 30
Quarterly report for FY2026 Q2
AI summary on its way
Revenue $210.93M
▲ 3.8%
Net loss $15.8M
Diluted EPS -$0.39
Aug 5
Aug 5
Jul 2
Jun 11
Current report
8-K
Director or officer change, or executive pay, Shareholder vote results
AI summary on its way
Jun 8
May 21
May 5
May 5
May 5
Quarterly report
10-Q
FY2026 Q1, ended Mar 31
Quarterly report for FY2026 Q1
AI summary on its way
Revenue $196.71M
▲ 1.6%
Net loss $20.91M
Diluted EPS -$0.52
Apr 29
Apr 29
Apr 9
Current report
8-K
Financial results, Director or officer change, or executive pay
AI summary on its way
Mar 3
Mar 2
Feb 24
Feb 24
Feb 24
Annual report
10-K
FY2025, ended Dec 31
Annual report for FY2025
AI summary on its way
Revenue $822.31M
▲ 2.9%
Net loss $92.19M
Diluted EPS -$2.33
2025
Nov 12
Investor event
Stifel 2025 Healthcare Conference
Nov 4
Earnings call
Q3 2025 earnings call
Nov 4
Current report
8-K
Financial results, Regulation FD disclosure
Nov 4
Quarterly report
10-Q
FY2025 Q3, ended Sep 30
Quarterly report for FY2025 Q3
Revenue $205.63M
▲ 4.6%
Net loss $22.8M
Diluted EPS -$0.57
Aug 5
Earnings call
Q2 2025 earnings call
Aug 5
Current report
8-K
Financial results, Regulation FD disclosure
Aug 5
Quarterly report
10-Q
FY2025 Q2, ended Jun 30
Quarterly report for FY2025 Q2
Revenue $203.12M
▲ 2.3%
Net loss $14.08M
Diluted EPS -$0.36
Jun 20
Current report
8-K
Events of Jun 18
Shareholder vote results
May 6
Earnings call
Q1 2025 earnings call
May 6
Current report
8-K
Financial results, Regulation FD disclosure
May 6
Quarterly report
10-Q
FY2025 Q1, ended Mar 31
Quarterly report for FY2025 Q1
Revenue $193.65M
▲ 2.7%
Net loss $53.09M
Diluted EPS -$1.35
Apr 30
Proxy statement
DEF 14A
Meeting Jun 18, 2025
Proxy statement
Apr 30
Proxy statement
DEFA14A
Proxy statement
Apr 7
Current report
8-K
Events of Apr 1
Entered into a material agreement, Ended a material agreement
Mar 12
Current report
8-K
Events of Mar 11
Director or officer change, or executive pay, Regulation FD disclosure
Feb 25
Earnings call
Q4 2024 earnings call
Feb 25
Current report
8-K
Financial results, Regulation FD disclosure
Feb 25
Annual report
10-K
FY2024, ended Dec 31
Annual report for FY2024
Revenue $799.49M
▲ 7.1%
Net loss $126M
Diluted EPS -$3.30
Feb 25
Registration statement
S-3ASR
Registration statement
2024
Nov 8
Current report
8-K
Events of Nov 7
Entered into a material agreement, Ended a material agreement, New debt or off-balance-sheet obligation
Nov 7
Earnings call
Q3 2024 earnings call
Nov 7
Current report
8-K
Financial results, Regulation FD disclosure
Nov 7
Quarterly report
10-Q
FY2024 Q3, ended Sep 30
Quarterly report for FY2024 Q3
Revenue $196.61M
▲ 6.8%
Net loss $27.39M
Diluted EPS -$0.71
Aug 6
Earnings call
Q2 2024 earnings call
Aug 6
Current report
8-K
Financial results, Regulation FD disclosure
Aug 6
Quarterly report
10-Q
FY2024 Q2, ended Jun 30
Quarterly report for FY2024 Q2
Revenue $198.62M
▲ 6.2%
Net loss $33.44M
Diluted EPS -$0.88
Jun 20
Current report
8-K
Events of Jun 18
Director or officer change, or executive pay, Shareholder vote results
Jun 6
Proxy statement
DEFA14A
Proxy statement
May 7
Earnings call
Q1 2024 earnings call
May 7
Current report
8-K
Financial results, Regulation FD disclosure
May 7
Quarterly report
10-Q
FY2024 Q1, ended Mar 31
Quarterly report for FY2024 Q1
Revenue $188.61M
▲ 7.7%
Net loss $36.02M
Diluted EPS -$0.95
Showing 1–50 of 160 documents
Key facts
CIK
884624
CUSIP
68752M108
13F (30d)
47 filings
35 filers
Visit website
Investor relations